Merrimack Pharmaceuticals Inc (MACK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Operating Expenses | 669 | 490 | 531 | 569 | 447 |
| Operating Income | -669 | -490 | -531 | -569 | -447 |
| Other Income | 233 | 262 | 252 | 178 | 176 |
| Pre-tax Income | -436 | -228 | -279 | -391 | -271 |
| Net Income Continuous | -436 | -240 | -279 | -391 | -271 |
| Net Income Discontinuous | 201,806 | N/A | N/A | N/A | N/A |
| Net Income | $201,370 | $-240 | $-279 | $-391 | $-271 |
| EPS Basic Total Ops | 13.93 | -0.01 | -0.02 | -0.03 | -0.02 |
| EPS Basic Continuous Ops | -0.03 | -0.02 | -0.02 | -0.03 | -0.02 |
| EPS Basic Discontinuous Ops | 13.96 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | 13.93 | -0.01 | -0.02 | -0.03 | -0.02 |
| EPS Diluted Continuous Ops | -0.03 | -0.02 | -0.02 | -0.03 | -0.02 |
| EPS Diluted Discontinuous Ops | 13.96 | N/A | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -0.03 | -0.01 | -0.02 | -0.03 | -0.02 |
| EBITDA(a) | $-669 | $-490 | $-670 | $-569 | $-447 |